Connection

Brian Hess to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Brian Hess has written about Antibodies, Monoclonal, Humanized.
Brian Hess
Connection Strength
0.191
Antibodies, Monoclonal, Humanized
  1. Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study. Blood Adv. 2022 08 23; 6(16):4736-4739.
    View in: PubMed
    Score: 0.191
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.